Figure 5.

Plasma concentrations of study drugs over time in treatment cycle 1. Blood samples were collected from 10 patients before treatment cycle 1 and at various time points throughout cycle 1. Plasma concentrations of (A) free and vascular endothelial growth factor (VEGF)‐bound aflibercept were determined using validated enzyme‐linked immunosorbent assays. Plasma concentrations of (B) irinotecan, SN‐38 and (C) 5‐fluorouracil (5‐FU) were determined using validated electrospray liquid chromatography tandem mass spectrometry